OMCL

Omnicell, Inc. Common Stock ($0.001 par value)

OMCL
Closed
$36.78
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Fort Worth, Texas and currently employs 3,580 full-time employees. The company went IPO on 2001-08-08. The firm is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. The company provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. The company provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Country

US

CEO

Mr. Randall Lipps

IPO date

2001

Employees

3,580

ISIN

US68213N1090

Key stats

Open

$38.18

Volume

792.38K

Market cap

$1.74B

Prev. close

$38.18

Impl / hst vl

-

Open interest

$0.00

$36.58

Day’s Range

$38.26

$31.75

52W Range

$55.00

Valuation

55
Valuation score
Fairly Valued
P/E
74.29
P/S
1.24
P/B
1.21
Current ratio
1.50
Debt / Equity
-0.06
ROE
1.64%
Gross margin
45.30%
Income growth
-660.61%
FCF growth
142.46

Analysts estimates

Consensus rating
Buy

The average rating from top 9 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$62.51
The top 9 analysts forecasts that 12-month price may increase by 69.96%, with a low of $55.55 and a high of $73.50
$55.55
Low
$62.51
Avg
$73.50
High
Current price

Earnings

Q1 ‘26 revenue
$309.88M
Q1 ‘26 net income
$11.36M
Revenue
Net income
Previous EPS
$0.55
Estimate EPS
$0.48
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply